Loading...
Some observational studies suggest excess cardiovascular (CV) risk in people with low vitamin D levels. To determine whether vitamin D supplementation prevents adverse CV events, about 5000 New Zealand adults (age range, 50–84) were randomized to receive either vitamin D3 (100,000 units once monthly) or placebo. At baseline, the mean 25-hydroxyvitamin D (25[OH]D) level was 25 ng/mL. About half the participants had no known cardiovascular (CV) disease. The other half were labeled as having CV disease, but hypertension was the most common diagnosis (only 6% had previous myocardial infarction).
Mean 25(OH)D levels doubled in the supplemented group and didn't change in the placebo group. However, during average follow-up of 3.3 years, the incide…